Clinical Trials Directory

Trials / Completed

CompletedNCT01183182

Safety and Effectiveness Study for a Needle Guidance System in Lung Biopsies

Confirmation of Clinical Effectiveness and Safety of CT-guided Percutaneous Lung Aspiration and Biopsy Performed With the Aid of the ActiSightTM Needle Guidance System

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
48 (actual)
Sponsor
ActiViews Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to provide clinical data regarding safety and clinical effectiveness of the ActiSight Needle Guidance System in assisting radiologically guided percutaneous needle biopsy or aspiration of pulmonary lesions, which is a common procedure.

Detailed description

This will be a prospective, single-arm study. At least three centers in Canada will participate in the study and at least 4 different experienced staff radiologists will perform the procedures for the study. A total of forty eight (48) consecutive subjects meeting the eligibility criteria, scheduled for clinically indicated CT guided lung biopsy or aspiration procedure at the participating centers will be invited to enroll in the study. To ensure diversity in the study population, consecutive patients will be enrolled in the following groups until these groups are fully enrolled: Lesion size ≥1.0 cm and ≤ 1.5 cm: 10 patients; Lesion size \>1.5 and ≤ 3.0 cm: 19 patients; Lesion size \>3.0 cm: 19 patients. A maximum of 24 patients will be enrolled at each center. Informed consent will be signed prior to the procedure. Subject data collection on the day of the procedure will include demographics, relevant medical history and vital signs. Enrolled subjects will undergo CT guided percutaneous lung aspiration and/or biopsy as clinically indicated by a qualified physician, utilizing the ActiSight Needle Guidance System. Subjects will be followed-up as outlined below to assess adverse events related to the procedure. A subject's enrollment in the study will be completed after the follow-up visit or after resolution of any procedure related adverse event. A procedure difficulty classification is defined for this study, based on existing literature. Difficulty levels for all procedures will be recorded and included in the final report.

Conditions

Interventions

TypeNameDescription
DEVICEActiSight Needle Guidance SystemThree different groups of patients defined per lesion size

Timeline

Start date
2010-08-01
Primary completion
2011-02-01
Completion
2011-03-01
First posted
2010-08-17
Last updated
2012-12-21

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT01183182. Inclusion in this directory is not an endorsement.